V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006001 | 300004107 | 1.55 | 51.5 | Palliative (P) | 2016-10-29 | 2016-11-09 | Trial Unspecified | N | N | 300008979 | CAV |
| 300006002 | 300004107 | 1.76 | 58.6 | Curative (C) | 2016-05-14 | 2016-05-21 | Cetuximab 7 day (>Cycle 2) | N | Y | 300008979 | CETUXIMAB + RT |
| 300006003 | 300008323 | 1.58 | 44.6 | Curative (C) | 2018-09-17 | 2018-10-25 | Carboplatin AUC 6 - 10 | N | Y | 300009003 | CARBOPLATIN |
| 300006004 | 300004108 | 1.77 | 74.2 | Curative (C) | 2014-02-17 | 2014-03-09 | CNS LGG Irinotecan & Bevacizumab | 02 | N | 300009006 | CAPECITABINE + GEMCITABINE |
| 300006005 | 300004108 | 1.72 | 57.4 | Palliative (P) | 2017-11-26 | 2017-12-02 | Cisplatin | 02 | N | 300009006 | CAPECITABINE |
| 300006006 | 300008253 | 1.65 | 55.8 | Palliative (P) | 2017-02-21 | 2017-02-22 | CETUXIMAB | 2 | N | 300009012 | OXALIPLATIN + MDG |
| 300006007 | 300004109 | 1.75 | 82 | null | 2017-08-14 | 2017-08-26 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300009014 | PACLITAXEL |
| 300006008 | 300006687 | 1.67 | 80 | Curative (C) | 2015-12-03 | 2015-12-03 | EOX | N | N | 300009019 | CARBO + FLUOROURACIL |
| 300006009 | 300006687 | 1.52 | 51.3 | Curative (C) | 2017-10-31 | 2017-11-30 | Alemtuzumab + Cyclophos TBI Allo | 02 | Y | 300009019 | CETUXIMAB |
| 300006010 | 300004112 | 1.65 | 42.4 | Curative (C) | 2017-12-11 | 2017-12-18 | Cetuximab + Radiotherapy Maint | 02 | Y | 300009033 | CETUXIMAB + RT |
| 300006011 | 300004113 | 1.76 | null | Curative (C) | 2014-08-07 | 2014-08-08 | CAPECITABINE + OXALIPLATIN | 2 | N | 300009042 | PACLITAXEL |
| 300006012 | 300004113 | 1.77 | 75.5 | Curative (C) | 2014-04-18 | 2014-04-22 | CISPLATIN + FLUOROURACIL | 02 | N | 300009042 | CISPLATIN |
| 300006013 | 300004114 | 1.65 | 89.7 | Curative (C) | 2016-01-02 | 2016-06-04 | Carboplatin AUC 2 - 5 | 02 | Y | 300009048 | CISPLATIN |
| 300006014 | 300004114 | null | null | Not known (9) | null | 2013-09-09 | DE-ESCALATE TRIAL | null | null | 300009048 | CISPLATIN + DOCETAXEL |
| 300006015 | 300004116 | 1.55 | 74.8 | Curative (C) | 2014-12-06 | 2015-02-17 | CARBOPLATIN + RT | N | Y | 300009058 | CISPLATIN |
| 300006016 | 300004117 | 1.49 | 44.6 | Palliative (P) | 2017-03-15 | 2017-03-15 | Cetuximab 7 day (Cycle 1) | 02 | N | 300009058 | CISPLATIN |
| 300006017 | 300004118 | 1.67 | 72.4 | null | 2013-03-04 | 2013-05-12 | Paclitaxel (2 or 3 weekly) | null | null | 300009064 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006018 | 300004118 | 1.74 | 78 | Not known (9) | 2014-08-28 | 2014-09-10 | Oxaliplatin + Modified de Gramont | 02 | null | 300009064 | OXALIPLATIN + MDG |
| 300006019 | 300004119 | 1.55 | 82.4 | Curative (C) | 2016-10-05 | 2016-10-30 | Cisplatin 7 day | N | Y | 300009074 | CISPLATIN |
| 300006020 | 300004119 | 1.8 | 61 | Curative (C) | 2017-07-15 | 2017-08-18 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300009074 | CISPLATIN |
| 300006021 | 300004120 | 1.55 | 70.7 | Curative (C) | 2017-06-28 | 2017-11-18 | Cisplatin 7 day | N | Y | 300009105 | CARBOPLATIN + RT |
| 300006022 | 300004121 | 1.83 | 95 | null | 2016-08-22 | 2016-08-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300009117 | ESPAC TRIAL |
| 300006023 | 300004122 | 1.79 | 82.2 | Palliative (P) | 2014-03-20 | 2014-04-05 | Cisplatin +Fluorouracil (3 wk) | N | Y | 300009118 | CETUXIMAB + RT |
| 300006024 | 300004123 | null | 68.6 | Curative (C) | 2017-09-11 | 2017-11-16 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300009122 | CETUXIMAB |
| 300006025 | 300004123 | null | null | Palliative (P) | null | 2015-09-28 | Cisplatin 7 day | null | null | 300009122 | DE-ESCALATE TRIAL |
| 300006026 | 300006697 | 1.54 | null | Curative (C) | 2016-05-17 | 2016-06-13 | ACTICCA-1 Trial | N | Y | 300009127 | CISPLATIN |
| 300006027 | 300004127 | 1.67 | null | Curative (C) | 2016-05-21 | 2016-06-03 | Folfirinox | 2 | N | 300009128 | BEVACIZUMAB |
| 300006028 | 300004128 | null | null | Curative (C) | null | 2016-11-18 | FLUOROURACIL + OXALIPLATIN | null | null | 300009138 | EPIRUBICIN INTRAVESICULAR |
| 300006029 | 300004128 | 1.76 | 74.85 | Curative (C) | 2014-07-25 | 2014-08-19 | Cisplatin 7 day | null | null | 300009138 | FEC |
| 300006030 | 300004132 | 1.57 | 61.15 | Curative (C) | 2013-06-27 | 2013-08-05 | Cetuximab 7 day (Cycle 1) | N | N | 300009149 | FLUOROURACIL |
| 300006031 | 300004132 | 1.63 | 63 | Curative (C) | null | 2015-06-28 | Cisplatin | N | Y | 300009149 | CETUXIMAB |
| 300006032 | 300004133 | 1.55 | null | Curative (C) | 2013-03-28 | 2013-04-11 | FLUOROURACIL + MITOMYCIN | N | null | 300009166 | PACLITAXEL |
| 300006033 | 300004133 | 1.65 | 76 | Curative (C) | 2013-04-01 | 2013-06-08 | Trial Unspecified | 02 | N | 300009166 | CAPECITABINE + GEMCITABINE |
| 300006034 | 300004134 | 1.6 | null | Curative (C) | 2015-02-06 | 2015-02-09 | CARBOPLATIN + RT | N | Y | 300009188 | CISPLATIN |
| 300006035 | 300004134 | 1.54 | 51.8 | Curative (C) | 2015-04-09 | 2015-04-09 | Cisplatin | 02 | Y | 300009188 | CISPLATIN |
| 300006036 | 300004135 | 1.62 | 55.9 | Adjuvant (A) | 2017-05-14 | 2017-05-14 | NPC Cisplatin/5 flourouracil | 02 | null | 300009199 | KESTREL TRIAL |
| 300006037 | 300004135 | 1.78 | 72.6 | Palliative (P) | 2017-03-23 | 2017-03-23 | FEC 100 | N | N | 300009199 | TEMOZOLOMIDE |
| 300006038 | 300004136 | 1.6 | 74.8 | Neo-adjuvant (N) | 2017-02-09 | 2017-03-10 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300009222 | CAPECITABINE |
| 300006039 | 300004137 | 1.49 | 59.15 | Curative (C) | 2017-04-07 | 2017-05-06 | Cisplatin | null | null | 300009248 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006040 | 300004137 | 1.64 | 95.6 | Curative (C) | null | 2018-01-10 | Cetuximab + Radiotherapy Maint | N | Y | 300009248 | CISPLATIN |
| 300006041 | 300004138 | 1.84 | 53.5 | Curative (C) | 2013-10-27 | 2013-11-17 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | Y | 300009256 | CETUXIMAB + RT |
| 300006042 | 300004139 | 1.58 | 57.7 | Adjuvant (A) | 2016-06-12 | 2016-06-15 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300009257 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006043 | 300004140 | 1.59 | null | Palliative (P) | null | 2014-12-10 | Oxaliplatin + Modified de Gramont | N | N | 300009261 | CAPECITABINE |
| 300006044 | 300004141 | 1.52 | 73.4 | Palliative (P) | 2018-05-23 | 2018-07-01 | Topotecan (intravenous) | N | N | 300009261 | MITOTANE |
| 300006045 | 300004142 | 1.77 | null | null | 2015-04-29 | 2015-06-18 | Cetuximab + Radiotherapy Maint | N | Y | 300009278 | CISPLATIN |
| 300006046 | 300004143 | 1.68 | 54.8 | Adjuvant (A) | 2017-06-20 | 2017-08-18 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 300009282 | AML19 TRIAL |
| 300006047 | 300004143 | 1.66 | 82 | Curative (C) | 2013-08-18 | 2013-12-25 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300009282 | CISPLATIN |
| 300006048 | 300004145 | 1.82 | 81.4 | Palliative (P) | 2016-02-18 | 2016-02-22 | Folfirinox | N | N | 300009289 | CAPECITABINE + GEMCITABINE |
| 300006049 | 300004147 | 1.8 | 107.8 | Curative (C) | 2015-12-06 | 2015-12-18 | DARS Trial | 02 | Y | 300009296 | CETUXIMAB |
| 300006050 | 300004148 | 1.73 | 69.2 | Curative (C) | 2016-12-22 | 2016-12-24 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 300009301 | CARBOPLATIN + RT |